Skip To Main Content
Xiaoxue Yin on Muck Rack

Xiaoxue Yin

As seen in: Journal of Clinical Pathology, MDPI, Genome Medicine, Molecular Cancer, The Journal of Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Xiaoxue

Contact Xiaoxue, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Enzyme-Assisted Fluorescence Biosensor Based on Circular Single-Stranded DNA Without Group Modification for MicroRNA Detection

|
By Xiaoxue Yin, Yazhen Liao, Feiyu Li, Jianbao Li
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Chaperone Copolymer-Assisted Catalytic Hairpin Assembly for Highly Sensitive Detection of Adenosine

|
By Yazhen Liao, Xiaoxue Yin, Wenqian Liu, Zhenrui Du
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma - Molecular Cancer Original

|
By Junjie Zhao, Yanfeng Tang, Xu Hu, Xiaoxue Yin, Yuntian Chen, Junru Chen, Haoyang Liu, Haolin Liu, Jiayu Liang, Xingming Zhang, Jinge Zhao, Sha Zhu, Yuchao Ni, Zhipeng Wang, Jindong Dai
| Molecular Cancer Verified
A total of 38 patients with metastatic TFE3-rRCC from our RCC database were enrolled in the study from January 2011 to February 2023. The median follow-up time was 28.8 months (range: 3.7-153.2). The baseline characteristics of the included patients are summarized in Suppl. Table 1 and Fig. 1A.
Open in Who Shared View Duplicates (2) Issue with article?
See all 12 licensed articles (13 Total)